- Nano cap Northwest Biotherapeutics (OTCQB:NWBO +49.8%) shows some oomph today on more than a 13x surge in volume. No particular news accounts for the unusual action, especially considering the market's down day.
- A week ago, Nasdaq informed the company that its remediation plan to address its failure to comply with listing rules regarding its unregistered issuance of securities to Cognate BioServices was acceptable and the company had regained compliance with rules. In other words, the matter has been closed.
- During the DCVax-L Phase 3 study in GBM brain cancer, NWBO paid some of Cognate's invoices in restricted stock instead of cash. The shares were unregistered despite contractual obligations to register them.
Northwest Bio up big but news scarce; shares up 50%
Recommended For You
About NWBO Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
NWBO | - | - |
Northwest Biotherapeutics, Inc. |